No takes yet. Share an insight, caveat, or question.
Randomized trial identifies potent LFA-1 antagonists, improving adhesion inhibition and reducing myocardial infarct size in rats, suggesting therapeutic benefits.
Pei et al. (2001) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: